News summary
[Tyenkang: The wholly-owned subsidiary obtained the drug registration certificate of Montelukast Sodium Granules] Securities Times e Company Newsslotdeposit30bonus30, Tyenkang (301263) announced on the evening of May 27 that its wholly-owned subsidiary Shandong Huabo Kaisheng Biotechnology Co., Ltd. recently received a certificate of Montelukast Sodium Granules issued by the State Food and Drug Administration.slotdeposit30bonus30...
Newsletter text
[Tyenkang: The wholly-owned subsidiary obtained the drug registration certificate for Montelukast Sodium Granules] Securities Times e Company News, Tyenkang (301263) announced on the evening of May 27 that its wholly-owned subsidiary Shandong Huabo Kaisheng Biotechnology Co., Ltd. Recently received the "Drug Registration Certificate" for Montelukast Sodium Granules issued by the State Food and Drug Administration. Montelukast Sodium Granules are suitable for the prevention and long-term treatment of asthma in children over 1 year old, including the prevention of asthma symptoms during the day and at night.